0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dry Eye Disease Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-17W10047
Home | Market Reports | Health| Vision Care
Global Dry Eye Disease Market Insights Forecast to 2028
BUY CHAPTERS

Global Dry Eye Disease Market Research Report 2024

Code: QYRE-Auto-17W10047
Report
January 2024
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dry Eye Disease Market Size

The global Dry Eye Disease market was valued at US$ 2397.5 million in 2023 and is anticipated to reach US$ 2949.6 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.

Dry Eye Disease Market

Dry Eye Disease Market

Dry eye disease is a multifactorial disease which is characterized by insufficiency of tears in eye. Insufficient lubrication in eye lead to burning, sensing, redness and pain in eye.
North American market for Dry Eye Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dry Eye Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dry Eye Disease include Santen Pharma, Novartis, Llergan, Takeda, TRB Chemedica, Sun Pharmaceutical, Senju Pharmaceutical, Sentiss Pharma and Johnson & Johnson, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dry Eye Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Eye Disease.

Report Scope

The Dry Eye Disease market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Eye Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dry Eye Disease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Dry Eye Disease Market Report

Report Metric Details
Report Name Dry Eye Disease Market
Accounted market size in 2023 US$ 2397.5 million
Forecasted market size in 2030 US$ 2949.6 million
CAGR 2.6%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Artificial Tears
  • Anti-inflammatory Drugs
  • Other
Segment by Application
  • Hospital
  • Drug Stores
  • Online Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Santen Pharma, Novartis, Llergan, Takeda, TRB Chemedica, Sun Pharmaceutical, Senju Pharmaceutical, Sentiss Pharma, Johnson & Johnson, Otsuka, Mitotech, FCI, Altacor, Valeant Pharmaceuticals, United Laboratories, Jianfeng Group, Eusan GMBH
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dry Eye Disease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Dry Eye Disease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Dry Eye Disease Market growing?

Ans: The Dry Eye Disease Market witnessing a CAGR of 2.6% during the forecast period 2024-2030.

What is the Dry Eye Disease Market size in 2030?

Ans: The Dry Eye Disease Market size in 2030 will be US$ 2949.6 million.

Who are the main players in the Dry Eye Disease Market report?

Ans: The main players in the Dry Eye Disease Market are Santen Pharma, Novartis, Llergan, Takeda, TRB Chemedica, Sun Pharmaceutical, Senju Pharmaceutical, Sentiss Pharma, Johnson & Johnson, Otsuka, Mitotech, FCI, Altacor, Valeant Pharmaceuticals, United Laboratories, Jianfeng Group, Eusan GMBH

What are the Application segmentation covered in the Dry Eye Disease Market report?

Ans: The Applications covered in the Dry Eye Disease Market report are Hospital, Drug Stores, Online Pharmacies

What are the Type segmentation covered in the Dry Eye Disease Market report?

Ans: The Types covered in the Dry Eye Disease Market report are Artificial Tears, Anti-inflammatory Drugs, Other

1 Dry Eye Disease Market Overview
1.1 Product Overview and Scope of Dry Eye Disease
1.2 Dry Eye Disease Segment by Type
1.2.1 Global Dry Eye Disease Market Value Comparison by Type (2024-2030)
1.2.2 Artificial Tears
1.2.3 Anti-inflammatory Drugs
1.2.4 Other
1.3 Dry Eye Disease Segment by Application
1.3.1 Global Dry Eye Disease Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Stores
1.3.4 Online Pharmacies
1.4 Global Dry Eye Disease Market Size Estimates and Forecasts
1.4.1 Global Dry Eye Disease Revenue 2019-2030
1.4.2 Global Dry Eye Disease Sales 2019-2030
1.4.3 Global Dry Eye Disease Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dry Eye Disease Market Competition by Manufacturers
2.1 Global Dry Eye Disease Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dry Eye Disease Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dry Eye Disease Average Price by Manufacturers (2019-2024)
2.4 Global Dry Eye Disease Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dry Eye Disease, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dry Eye Disease, Product Type & Application
2.7 Dry Eye Disease Market Competitive Situation and Trends
2.7.1 Dry Eye Disease Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dry Eye Disease Players Market Share by Revenue
2.7.3 Global Dry Eye Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dry Eye Disease Retrospective Market Scenario by Region
3.1 Global Dry Eye Disease Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dry Eye Disease Global Dry Eye Disease Sales by Region: 2019-2030
3.2.1 Global Dry Eye Disease Sales by Region: 2019-2024
3.2.2 Global Dry Eye Disease Sales by Region: 2025-2030
3.3 Global Dry Eye Disease Global Dry Eye Disease Revenue by Region: 2019-2030
3.3.1 Global Dry Eye Disease Revenue by Region: 2019-2024
3.3.2 Global Dry Eye Disease Revenue by Region: 2025-2030
3.4 North America Dry Eye Disease Market Facts & Figures by Country
3.4.1 North America Dry Eye Disease Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dry Eye Disease Sales by Country (2019-2030)
3.4.3 North America Dry Eye Disease Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dry Eye Disease Market Facts & Figures by Country
3.5.1 Europe Dry Eye Disease Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dry Eye Disease Sales by Country (2019-2030)
3.5.3 Europe Dry Eye Disease Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dry Eye Disease Market Facts & Figures by Country
3.6.1 Asia Pacific Dry Eye Disease Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dry Eye Disease Sales by Country (2019-2030)
3.6.3 Asia Pacific Dry Eye Disease Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dry Eye Disease Market Facts & Figures by Country
3.7.1 Latin America Dry Eye Disease Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dry Eye Disease Sales by Country (2019-2030)
3.7.3 Latin America Dry Eye Disease Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dry Eye Disease Market Facts & Figures by Country
3.8.1 Middle East and Africa Dry Eye Disease Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dry Eye Disease Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dry Eye Disease Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dry Eye Disease Sales by Type (2019-2030)
4.1.1 Global Dry Eye Disease Sales by Type (2019-2024)
4.1.2 Global Dry Eye Disease Sales by Type (2025-2030)
4.1.3 Global Dry Eye Disease Sales Market Share by Type (2019-2030)
4.2 Global Dry Eye Disease Revenue by Type (2019-2030)
4.2.1 Global Dry Eye Disease Revenue by Type (2019-2024)
4.2.2 Global Dry Eye Disease Revenue by Type (2025-2030)
4.2.3 Global Dry Eye Disease Revenue Market Share by Type (2019-2030)
4.3 Global Dry Eye Disease Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dry Eye Disease Sales by Application (2019-2030)
5.1.1 Global Dry Eye Disease Sales by Application (2019-2024)
5.1.2 Global Dry Eye Disease Sales by Application (2025-2030)
5.1.3 Global Dry Eye Disease Sales Market Share by Application (2019-2030)
5.2 Global Dry Eye Disease Revenue by Application (2019-2030)
5.2.1 Global Dry Eye Disease Revenue by Application (2019-2024)
5.2.2 Global Dry Eye Disease Revenue by Application (2025-2030)
5.2.3 Global Dry Eye Disease Revenue Market Share by Application (2019-2030)
5.3 Global Dry Eye Disease Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Santen Pharma
6.1.1 Santen Pharma Corporation Information
6.1.2 Santen Pharma Description and Business Overview
6.1.3 Santen Pharma Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Santen Pharma Dry Eye Disease Product Portfolio
6.1.5 Santen Pharma Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Dry Eye Disease Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Llergan
6.3.1 Llergan Corporation Information
6.3.2 Llergan Description and Business Overview
6.3.3 Llergan Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Llergan Dry Eye Disease Product Portfolio
6.3.5 Llergan Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Corporation Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Takeda Dry Eye Disease Product Portfolio
6.4.5 Takeda Recent Developments/Updates
6.5 TRB Chemedica
6.5.1 TRB Chemedica Corporation Information
6.5.2 TRB Chemedica Description and Business Overview
6.5.3 TRB Chemedica Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.5.4 TRB Chemedica Dry Eye Disease Product Portfolio
6.5.5 TRB Chemedica Recent Developments/Updates
6.6 Sun Pharmaceutical
6.6.1 Sun Pharmaceutical Corporation Information
6.6.2 Sun Pharmaceutical Description and Business Overview
6.6.3 Sun Pharmaceutical Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sun Pharmaceutical Dry Eye Disease Product Portfolio
6.6.5 Sun Pharmaceutical Recent Developments/Updates
6.7 Senju Pharmaceutical
6.6.1 Senju Pharmaceutical Corporation Information
6.6.2 Senju Pharmaceutical Description and Business Overview
6.6.3 Senju Pharmaceutical Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Senju Pharmaceutical Dry Eye Disease Product Portfolio
6.7.5 Senju Pharmaceutical Recent Developments/Updates
6.8 Sentiss Pharma
6.8.1 Sentiss Pharma Corporation Information
6.8.2 Sentiss Pharma Description and Business Overview
6.8.3 Sentiss Pharma Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sentiss Pharma Dry Eye Disease Product Portfolio
6.8.5 Sentiss Pharma Recent Developments/Updates
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Corporation Information
6.9.2 Johnson & Johnson Description and Business Overview
6.9.3 Johnson & Johnson Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Johnson & Johnson Dry Eye Disease Product Portfolio
6.9.5 Johnson & Johnson Recent Developments/Updates
6.10 Otsuka
6.10.1 Otsuka Corporation Information
6.10.2 Otsuka Description and Business Overview
6.10.3 Otsuka Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Otsuka Dry Eye Disease Product Portfolio
6.10.5 Otsuka Recent Developments/Updates
6.11 Mitotech
6.11.1 Mitotech Corporation Information
6.11.2 Mitotech Dry Eye Disease Description and Business Overview
6.11.3 Mitotech Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mitotech Dry Eye Disease Product Portfolio
6.11.5 Mitotech Recent Developments/Updates
6.12 FCI
6.12.1 FCI Corporation Information
6.12.2 FCI Dry Eye Disease Description and Business Overview
6.12.3 FCI Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.12.4 FCI Dry Eye Disease Product Portfolio
6.12.5 FCI Recent Developments/Updates
6.13 Altacor
6.13.1 Altacor Corporation Information
6.13.2 Altacor Dry Eye Disease Description and Business Overview
6.13.3 Altacor Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Altacor Dry Eye Disease Product Portfolio
6.13.5 Altacor Recent Developments/Updates
6.14 Valeant Pharmaceuticals
6.14.1 Valeant Pharmaceuticals Corporation Information
6.14.2 Valeant Pharmaceuticals Dry Eye Disease Description and Business Overview
6.14.3 Valeant Pharmaceuticals Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Valeant Pharmaceuticals Dry Eye Disease Product Portfolio
6.14.5 Valeant Pharmaceuticals Recent Developments/Updates
6.15 United Laboratories
6.15.1 United Laboratories Corporation Information
6.15.2 United Laboratories Dry Eye Disease Description and Business Overview
6.15.3 United Laboratories Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.15.4 United Laboratories Dry Eye Disease Product Portfolio
6.15.5 United Laboratories Recent Developments/Updates
6.16 Jianfeng Group
6.16.1 Jianfeng Group Corporation Information
6.16.2 Jianfeng Group Dry Eye Disease Description and Business Overview
6.16.3 Jianfeng Group Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Jianfeng Group Dry Eye Disease Product Portfolio
6.16.5 Jianfeng Group Recent Developments/Updates
6.17 Eusan GMBH
6.17.1 Eusan GMBH Corporation Information
6.17.2 Eusan GMBH Dry Eye Disease Description and Business Overview
6.17.3 Eusan GMBH Dry Eye Disease Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Eusan GMBH Dry Eye Disease Product Portfolio
6.17.5 Eusan GMBH Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dry Eye Disease Industry Chain Analysis
7.2 Dry Eye Disease Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dry Eye Disease Production Mode & Process
7.4 Dry Eye Disease Sales and Marketing
7.4.1 Dry Eye Disease Sales Channels
7.4.2 Dry Eye Disease Distributors
7.5 Dry Eye Disease Customers
8 Dry Eye Disease Market Dynamics
8.1 Dry Eye Disease Industry Trends
8.2 Dry Eye Disease Market Drivers
8.3 Dry Eye Disease Market Challenges
8.4 Dry Eye Disease Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Dry Eye Disease Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Dry Eye Disease Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Dry Eye Disease Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Dry Eye Disease Sales (Kg) of Key Manufacturers (2019-2024)
    Table 5. Global Dry Eye Disease Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Dry Eye Disease Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Dry Eye Disease Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Dry Eye Disease Average Price (USD/Kg) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Dry Eye Disease, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Dry Eye Disease, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Dry Eye Disease, Product Type & Application
    Table 12. Global Key Manufacturers of Dry Eye Disease, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Dry Eye Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dry Eye Disease as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Dry Eye Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Dry Eye Disease Sales by Region (2019-2024) & (Kg)
    Table 18. Global Dry Eye Disease Sales Market Share by Region (2019-2024)
    Table 19. Global Dry Eye Disease Sales by Region (2025-2030) & (Kg)
    Table 20. Global Dry Eye Disease Sales Market Share by Region (2025-2030)
    Table 21. Global Dry Eye Disease Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Dry Eye Disease Revenue Market Share by Region (2019-2024)
    Table 23. Global Dry Eye Disease Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Dry Eye Disease Revenue Market Share by Region (2025-2030)
    Table 25. North America Dry Eye Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Dry Eye Disease Sales by Country (2019-2024) & (Kg)
    Table 27. North America Dry Eye Disease Sales by Country (2025-2030) & (Kg)
    Table 28. North America Dry Eye Disease Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Dry Eye Disease Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Dry Eye Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Dry Eye Disease Sales by Country (2019-2024) & (Kg)
    Table 32. Europe Dry Eye Disease Sales by Country (2025-2030) & (Kg)
    Table 33. Europe Dry Eye Disease Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Dry Eye Disease Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Dry Eye Disease Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Dry Eye Disease Sales by Region (2019-2024) & (Kg)
    Table 37. Asia Pacific Dry Eye Disease Sales by Region (2025-2030) & (Kg)
    Table 38. Asia Pacific Dry Eye Disease Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Dry Eye Disease Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Dry Eye Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Dry Eye Disease Sales by Country (2019-2024) & (Kg)
    Table 42. Latin America Dry Eye Disease Sales by Country (2025-2030) & (Kg)
    Table 43. Latin America Dry Eye Disease Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Dry Eye Disease Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Dry Eye Disease Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Dry Eye Disease Sales by Country (2019-2024) & (Kg)
    Table 47. Middle East & Africa Dry Eye Disease Sales by Country (2025-2030) & (Kg)
    Table 48. Middle East & Africa Dry Eye Disease Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Dry Eye Disease Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Dry Eye Disease Sales (Kg) by Type (2019-2024)
    Table 51. Global Dry Eye Disease Sales (Kg) by Type (2025-2030)
    Table 52. Global Dry Eye Disease Sales Market Share by Type (2019-2024)
    Table 53. Global Dry Eye Disease Sales Market Share by Type (2025-2030)
    Table 54. Global Dry Eye Disease Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Dry Eye Disease Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Dry Eye Disease Revenue Market Share by Type (2019-2024)
    Table 57. Global Dry Eye Disease Revenue Market Share by Type (2025-2030)
    Table 58. Global Dry Eye Disease Price (USD/Kg) by Type (2019-2024)
    Table 59. Global Dry Eye Disease Price (USD/Kg) by Type (2025-2030)
    Table 60. Global Dry Eye Disease Sales (Kg) by Application (2019-2024)
    Table 61. Global Dry Eye Disease Sales (Kg) by Application (2025-2030)
    Table 62. Global Dry Eye Disease Sales Market Share by Application (2019-2024)
    Table 63. Global Dry Eye Disease Sales Market Share by Application (2025-2030)
    Table 64. Global Dry Eye Disease Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Dry Eye Disease Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Dry Eye Disease Revenue Market Share by Application (2019-2024)
    Table 67. Global Dry Eye Disease Revenue Market Share by Application (2025-2030)
    Table 68. Global Dry Eye Disease Price (USD/Kg) by Application (2019-2024)
    Table 69. Global Dry Eye Disease Price (USD/Kg) by Application (2025-2030)
    Table 70. Santen Pharma Corporation Information
    Table 71. Santen Pharma Description and Business Overview
    Table 72. Santen Pharma Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 73. Santen Pharma Dry Eye Disease Product
    Table 74. Santen Pharma Recent Developments/Updates
    Table 75. Novartis Corporation Information
    Table 76. Novartis Description and Business Overview
    Table 77. Novartis Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 78. Novartis Dry Eye Disease Product
    Table 79. Novartis Recent Developments/Updates
    Table 80. Llergan Corporation Information
    Table 81. Llergan Description and Business Overview
    Table 82. Llergan Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 83. Llergan Dry Eye Disease Product
    Table 84. Llergan Recent Developments/Updates
    Table 85. Takeda Corporation Information
    Table 86. Takeda Description and Business Overview
    Table 87. Takeda Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 88. Takeda Dry Eye Disease Product
    Table 89. Takeda Recent Developments/Updates
    Table 90. TRB Chemedica Corporation Information
    Table 91. TRB Chemedica Description and Business Overview
    Table 92. TRB Chemedica Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 93. TRB Chemedica Dry Eye Disease Product
    Table 94. TRB Chemedica Recent Developments/Updates
    Table 95. Sun Pharmaceutical Corporation Information
    Table 96. Sun Pharmaceutical Description and Business Overview
    Table 97. Sun Pharmaceutical Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 98. Sun Pharmaceutical Dry Eye Disease Product
    Table 99. Sun Pharmaceutical Recent Developments/Updates
    Table 100. Senju Pharmaceutical Corporation Information
    Table 101. Senju Pharmaceutical Description and Business Overview
    Table 102. Senju Pharmaceutical Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 103. Senju Pharmaceutical Dry Eye Disease Product
    Table 104. Senju Pharmaceutical Recent Developments/Updates
    Table 105. Sentiss Pharma Corporation Information
    Table 106. Sentiss Pharma Description and Business Overview
    Table 107. Sentiss Pharma Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 108. Sentiss Pharma Dry Eye Disease Product
    Table 109. Sentiss Pharma Recent Developments/Updates
    Table 110. Johnson & Johnson Corporation Information
    Table 111. Johnson & Johnson Description and Business Overview
    Table 112. Johnson & Johnson Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 113. Johnson & Johnson Dry Eye Disease Product
    Table 114. Johnson & Johnson Recent Developments/Updates
    Table 115. Otsuka Corporation Information
    Table 116. Otsuka Description and Business Overview
    Table 117. Otsuka Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 118. Otsuka Dry Eye Disease Product
    Table 119. Otsuka Recent Developments/Updates
    Table 120. Mitotech Corporation Information
    Table 121. Mitotech Description and Business Overview
    Table 122. Mitotech Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 123. Mitotech Dry Eye Disease Product
    Table 124. Mitotech Recent Developments/Updates
    Table 125. FCI Corporation Information
    Table 126. FCI Description and Business Overview
    Table 127. FCI Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 128. FCI Dry Eye Disease Product
    Table 129. FCI Recent Developments/Updates
    Table 130. Altacor Corporation Information
    Table 131. Altacor Description and Business Overview
    Table 132. Altacor Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 133. Altacor Dry Eye Disease Product
    Table 134. Altacor Recent Developments/Updates
    Table 135. Valeant Pharmaceuticals Corporation Information
    Table 136. Valeant Pharmaceuticals Description and Business Overview
    Table 137. Valeant Pharmaceuticals Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 138. Valeant Pharmaceuticals Dry Eye Disease Product
    Table 139. Valeant Pharmaceuticals Recent Developments/Updates
    Table 140. United Laboratories Corporation Information
    Table 141. United Laboratories Description and Business Overview
    Table 142. United Laboratories Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 143. United Laboratories Dry Eye Disease Product
    Table 144. United Laboratories Recent Developments/Updates
    Table 145. Jianfeng Group Corporation Information
    Table 146. Jianfeng Group Description and Business Overview
    Table 147. Jianfeng Group Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 148. Jianfeng Group Dry Eye Disease Product
    Table 149. Jianfeng Group Recent Developments/Updates
    Table 150. Eusan GMBH Corporation Information
    Table 151. Eusan GMBH Description and Business Overview
    Table 152. Eusan GMBH Dry Eye Disease Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 153. Eusan GMBH Dry Eye Disease Product
    Table 154. Eusan GMBH Recent Developments/Updates
    Table 155. Key Raw Materials Lists
    Table 156. Raw Materials Key Suppliers Lists
    Table 157. Dry Eye Disease Distributors List
    Table 158. Dry Eye Disease Customers List
    Table 159. Dry Eye Disease Market Trends
    Table 160. Dry Eye Disease Market Drivers
    Table 161. Dry Eye Disease Market Challenges
    Table 162. Dry Eye Disease Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Dry Eye Disease
    Figure 2. Global Dry Eye Disease Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Dry Eye Disease Market Share by Type in 2023 & 2030
    Figure 4. Artificial Tears Product Picture
    Figure 5. Anti-inflammatory Drugs Product Picture
    Figure 6. Other Product Picture
    Figure 7. Global Dry Eye Disease Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Dry Eye Disease Market Share by Application in 2023 & 2030
    Figure 9. Hospital
    Figure 10. Drug Stores
    Figure 11. Online Pharmacies
    Figure 12. Global Dry Eye Disease Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Dry Eye Disease Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Dry Eye Disease Sales (2019-2030) & (Kg)
    Figure 15. Global Dry Eye Disease Average Price (USD/Kg) & (2019-2030)
    Figure 16. Dry Eye Disease Report Years Considered
    Figure 17. Dry Eye Disease Sales Share by Manufacturers in 2023
    Figure 18. Global Dry Eye Disease Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Dry Eye Disease Players: Market Share by Revenue in 2023
    Figure 20. Dry Eye Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Dry Eye Disease Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Dry Eye Disease Sales Market Share by Country (2019-2030)
    Figure 23. North America Dry Eye Disease Revenue Market Share by Country (2019-2030)
    Figure 24. U.S. Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Dry Eye Disease Sales Market Share by Country (2019-2030)
    Figure 27. Europe Dry Eye Disease Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Dry Eye Disease Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Dry Eye Disease Revenue Market Share by Region (2019-2030)
    Figure 35. China Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Taiwan Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Philippines Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Latin America Dry Eye Disease Sales Market Share by Country (2019-2030)
    Figure 46. Latin America Dry Eye Disease Revenue Market Share by Country (2019-2030)
    Figure 47. Mexico Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Brazil Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Argentina Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Middle East & Africa Dry Eye Disease Sales Market Share by Country (2019-2030)
    Figure 51. Middle East & Africa Dry Eye Disease Revenue Market Share by Country (2019-2030)
    Figure 52. Turkey Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. U.A.E Dry Eye Disease Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Global Sales Market Share of Dry Eye Disease by Type (2019-2030)
    Figure 56. Global Revenue Market Share of Dry Eye Disease by Type (2019-2030)
    Figure 57. Global Dry Eye Disease Price (USD/Kg) by Type (2019-2030)
    Figure 58. Global Sales Market Share of Dry Eye Disease by Application (2019-2030)
    Figure 59. Global Revenue Market Share of Dry Eye Disease by Application (2019-2030)
    Figure 60. Global Dry Eye Disease Price (USD/Kg) by Application (2019-2030)
    Figure 61. Dry Eye Disease Value Chain
    Figure 62. Dry Eye Disease Production Process
    Figure 63. Channels of Distribution (Direct Vs Distribution)
    Figure 64. Distributors Profiles
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS